Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

Journal
The Lancet
ISSN
0140-6736
Date Issued
2017
Author(s)
Levin, Adeera
Tonelli, Marcello
Bonventre, Joseph
Coresh, Josef
Donner, Jo-Ann
Fogo, Agnes B.
Fox, Caroline S.
Gansevoort, Ron T.
Heerspink, Hiddo J.L.
Jardine, Meg
Kasiske, Bertram
Köttgen, Anna
Kretzler, Matthias
Levey, Andrew S.
Luyckx, Valerie A.
Mehta, Ravindra
Moe, Orson
Pannu, Neesh
Parikh, Chirag R.
Perkovic, Vlado
Pollock, Carol
Stenvinkel, Peter
Tuttle, Katherine R.
Wheeler, David C.
Eckardt, Kai-uwe
Type
text::journal::journal article
DOI
URL
Abstract
The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5–10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury—a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide. © The Lancet